Supreme Court Justices Question Trump Administration on Tariffs
P.M. Edition for Nov. 5. The U.S. Supreme Court heard oral arguments over President Trump’s global tariffs, and whether he exceeded his authority to impose them. WSJ Supreme Court correspondent Jess Bravin discusses the justices’ responses. Plus, we hear from Journal White House reporter Meridith McGraw on the president’s reaction to Democrats’ election victories: he’s urging Republican lawmakers to end the filibuster. And OpenAI’s CFO says that the company is not looking to go public in the near term. Alex Ossola hosts.
Sign up for the WSJ's free What's News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
--------
13:51
--------
13:51
Democrats Sweep With Big Wins in New York, Virginia and New Jersey
A.M. Edition for Nov. 5. Democrats notched major victories last night, prompting President Trump’s ire on social media. WSJ editor Aaron Zitner breaks down what the results mean for both parties and how they could shape the national political landscape going into the 2026 midterms. Plus, Republican senators meet at the White House this morning as the government shutdown becomes the longest in history. And we look at the competition facing weight-loss giant Novo Nordisk. Caitlin McCabe hosts.
Sign up for the WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
--------
13:05
--------
13:05
Government Shutdown Poised to Become Longest in U.S. History
P.M. Edition for Nov. 4. WSJ’s Congress reporter Katy Stech Ferek talks about the latest in negotiations as lawmakers search for a deal to end the shutdown. Spencer Jakab, who writes WSJ’s Markets A.M. newsletter, explains why a famous method of valuing stocks suggests rough years ahead. And it’s Election Day in the U.S. Head to WSJ’s live blog for more coverage of key races in New York City, New Jersey and Virginia. Sabrina Siddiqui hosts.
Sign up for the WSJ's free What's News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
--------
12:29
--------
12:29
What’s News in Earnings: Who Is Winning the Obesity-Drug Arms Race?
Bonus Episode for Nov. 4. The weight-loss-drug arms race is only heating up, as Novo Nordisk attempts to snatch drugmaker Metsera away from Pfizer. But can either company compete with Zepbound seller Eli Lilly? WSJ reporter Peter Loftus discusses what earnings from Big Pharma, including AbbVie, Bristol Myers Squibb and Merck, say about the future of the industry and how companies are responding to President Trump’s drug-pricing plans, including TrumpRx.
WSJ Heard on the Street columnist David Wainer hosts this special bonus episode of What's News in Earnings, where we dig into companies’ earnings reports and analyst calls to find out what’s going on under the hood of the American economy.
Sign up for the WSJ's free Markets A.M. newsletter.
Further Reading:
Novo Nordisk Sweetens Offer for Metsera - WSJ
Pfizer Sues Seeking to Block Novo Nordisk’s Effort to Undo Weight-Loss Drug Deal
Why Pfizer Can Still Prevail in the Obesity Fight With Novo Nordisk
The Day Pharma’s Weight-Loss Gold Rush Intensified
Pfizer Profit Falls Amid Lower Covid-19 Drug Demand
Novo Nordisk Seeks to Outmuscle Pfizer With $9 Billion Bid for Metsera
Novo Nordisk to Shake Up Board After Obesity-Market Challenges
Mounjaro Powers Eli Lilly to Bumper Quarter of Earnings
AbbVie Lifts Profit Outlook as Sales Rise
Bristol Myers Squibb Profit Soars, Raises Revenue Guidance
Merck Profit Rises on Strong Keytruda Demand
GSK Lifts Guidance After Specialty Medicines Boost Sales
Novartis Expects to Ride Out Patent Losses With Sales, Profit Growth Ahead
Biogen Cuts Full-Year Earnings Guidance, Despite Third-Quarter Profit Rise
J&J Lifts Full-Year Sales Outlook, Fueled by Pharma, Med-Device Gains
Learn more about your ad choices. Visit megaphone.fm/adchoices
--------
7:47
--------
7:47
Trump Backs Cuomo in New York Mayoral Race
A.M. Edition for Nov. 4. It is election day with voters heading to the polls in states including New York, Virginia and New Jersey. WSJ’s John McCormick says that although Democrats are expected to win all three races, it will not necessarily ease the divided party’s troubles. Plus, WSJ’s Gavin Bade says there is a lot at stake for President Trump as his tariffs are set to go before the Supreme Court. And two major investors reject Elon Musk’s $1 trillion pay deal. Caitlin McCabe hosts.
Sign up for the WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
What's News brings you the biggest news of the day, from business and finance to global and political developments that move markets. Get caught up in minutes twice a day on weekdays, then take a step back with our What’s News in Markets wrap-up on Saturday and our What’s News Sunday deep dive.
Brasil